Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Euronext Paris  >  NicOx SA    NCOX   FR0000074130

NICOX SA (NCOX)
Mes dernières consult.
Top consult.
  Rapport  
Cours en clôture. Cours en clôture  - 03/12
7.235 EUR   -7.95%
08/01NICOX : bondit sur une recommandation de broker
CF
08/01NICOX : Bryan Garnier remonte a cible
CF
03/01NICOX : nomination d'un head of development
CF
SynthèseGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
Métier
Logo NicOx SA
Developes and manufactures biopharmaceuticals

Nicox SA is an ophthalmology company, which engages in developing innovative solutions to help maintain vision and improve ocular health.

Its products include Zerviate, and Vyzulta.

The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.
Dirigeants
Nom AgeDepuisTitre
Michele Garufi631996Chairman & Chief Executive Officer
Sandrine Gestin501999Vice President-Finance
Michael Bergamini, PhD-2014Chief Scientific Officer & Executive VP
Jean-François Labbé, MBA672010Director
Birgit Stattin Norinder702011Director
Adrienne L. Graves, PhD652014Director
Luzi Andreas von Bidder652014Director
Lester J. Kaplan, PhD672014Director
Lauren P. Silvernail, MBA592017Director
Gavin M. Spencer, PhD472005Chief Business Officer & Executive Vice President
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 25 730 325 24 093 240 93.6% 60 987 0.2% 93.6%
Actionnaires
Nom Actions%
HBM Partners AG 1 713 313 5,82%
Bpifrance Participations SA /PRIVATE EQUITY/ 790 514 2,68%
OFI Asset Management SA 214 797 0,73%
Michele Garufi 213 051 0,72%
Santander Private Banking Gestion SA SGIIC 208 171 0,71%
Dimensional Fund Advisors LP 199 750 0,68%
Apo Asset Management GmbH 194 143 0,66%
NEA Management Co. LLC 141 187 0,48%
Medical Strategy GmbH 119 654 0,41%
OP Asset Management Ltd. 92 977 0,32%
Participations
Nom Actions%Valorisation
Nicox (COX) 60 9870,21%753 668 USD
Coordonnées société
Nicox SA
Drakkar 2 - Bât D
2405 route des Dolines
Sophia-Antipolis, Provence-Alpes-Cote-dAzur 06560

Phone : +33.4.97.24.53.00
Fax : +33.4.97.24.53.99
Web : www.nicox.com
Secteur Pharmacies spécialisées et de pointe
Connexions : NicOx SA
Relivia SRL
Delife SRL
American Academy of Ophthalmology, Inc.
Partners för Utvecklingsinvesteringar inom Life Sciences AB
Wingfirm Pharma AB
Envisia Therapeutics, Inc.
The Clinical Research Institute of the Foundation
Women in Ophthalmology
Navigation Dynamics AB
Keck Graduate Institute of Applied Life Sciences
Wntresearch AB
Aciex Therapeutics, Inc.
The Association for Research in Vision & Ophthalmology
Ferring International Center SA
American Glaucoma Society
Ferring Pharmaceuticals SA
American Academy of Ophthalmology Foundation
The American Society of Cataract & Refractive Surgery
Ferring Holding SA
Glaucoma Research Foundation
Neurotech Pharmaceuticals, Inc. (United States)
KeepYourSight Foundation
Medinox, Inc.
Licensing Executives Society
FFB Clinical Research Institute
Pan-American Ophthalmological Foundation
Himalayan Cataract Project
Apparity LLC
© 2018 People , Fundamentals and Ownership